MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Sep 24, 2025 · CIK: 1878313
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
MAIA Bio filed an 8-K on 9/24/25, check for updates.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on September 24, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is based in Chicago, IL, and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates MAIA Biotechnology is providing updates on its corporate activities and financial status to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing with no immediate negative or positive financial implications disclosed.
Key Numbers
- 001-41455 — SEC File Number (Identifies the company's filing with the SEC.)
- 83-1495913 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- September 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Chicago, IL (location) — Principal executive offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific 'Other Events' are being reported by MAIA Biotechnology, Inc. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the primary business of MAIA Biotechnology, Inc. according to the SIC code?
The Standard Industrial Classification (SIC) code provided is 2834, which corresponds to 'Pharmaceutical Preparations'.
When was the earliest event reported in this Form 8-K?
The earliest event reported in this Form 8-K was on September 24, 2025.
Where are MAIA Biotechnology, Inc.'s principal executive offices located?
MAIA Biotechnology, Inc.'s principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the SEC file number for MAIA Biotechnology, Inc.?
The SEC file number for MAIA Biotechnology, Inc. is 001-41455.
Filing Stats: 796 words · 3 min read · ~3 pages · Grade level 14.3 · Accepted 2025-09-24 08:25:30
Key Financial Figures
- $2.3 Million — press release announcing the award of a $2.3 Million grant by National Institutes of Health
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 19KB
- 0001493152-25-014729.txt ( ) — 230KB
- maia-20250924.xsd (EX-101.SCH) — 3KB
- maia-20250924_lab.xml (EX-101.LAB) — 33KB
- maia-20250924_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 24, 2025 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer 3